Skip to main content

Corporate insider profile

Pamela Wapnick Insider Trades

Latest reported as Chief Financial Officer of Metagenomi Therapeutics, Inc. (MGX).

Purchase filings
0
Reported companies
1
Net open-market value
-$5,960.02
Latest transaction
Sep 8, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 8, 2026Metagenomi Therapeutics, Inc. (MGX)Chief Financial OfficerSale1,911$1.16$2,214
Jun 5, 2026Metagenomi Therapeutics, Inc. (MGX)Chief Financial OfficerSale2,884$1.30$3,746